Study Identifies Hypothyroidism Among Patients Taking Sunitinib - News
Study Identifies Hypothyroidism Among Patients Taking Sunitinib
Fri, 05 Jan 2007 07:00 PM EST
... Abnormal thyroid function is common among patients with metastatic renal cell carcinoma taking a new drug called sunitinib, and these patients' thyroid levels should be routinely monitored, a new study finds.Sunitinib was recently approved for the treatment of advanced renal cell carcinoma. [click link for full article] ...
- Newborn Care
- Taking Care of Your Voice
- Cost of Falls Among Older Adults
- Health Disparities
- Tobacco Use
- Youth Suicide
- Teen Violence
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Seizures (in about half of patients)
- Radiation Studies
- Peptic Ulcer